Dergiler / The anatolian journal of family medicine (Online) / 2021 / Cilt: 4 - Sayı: 1

Antihypertensive Management in Children: A Two-years Experience of Indonesia’s National Referral Hospital

Sayfa
7–12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The therapeutic effect of antihypertensive drugs was expected within 28 days of treatment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The prevalence of hypertension (HT) in children has increased overtime.
📊
Temel Bulgular & Veri:Methods: A retrospective cross-sectional study was conducted in CMGH from January 2016 to December 2017.
💡
Sonuç & Katkı:The therapeutic effect of antihypertensive drugs was expected within 28 days of treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The prevalence of hypertension (HT) in children has increased overtime. However, data related to antihypertensive options and outcomes are still limited in children, especially in Indonesia. This study aimed to describe pediatric HT cases and antihypertensive management in Cipto Mangunkusumo General Hospital (CMGH). Methods: A retrospective cross-sectional study was conducted in CMGH from January 2016 to December 2017. Inclusion criteria were children age <18 years with primary and secondary HT visiting pediatric nephrol- ogy clinic. Patients were excluded if no blood pressure records were found. Clinical and antihypertensive treat- ments data were recorded from medical records. Diagnosis was based on the Fourth Report classification. Results: This study included 176 children with HT. Secondary HT was found in 159 (90.3%) patients, and 82 (51.6%) of them had isolated kidney–urinary tract disease. Dual antihypertensive therapy was prescribed for 53 (30.1%) patients, whereas 55 (31.3%) patients was monotherapy. The most common antihypertensive used in monotherapy was angiotensin converting enzyme inhibitors (ACEI), received by 31 (56.3%) patients. The median duration of therapy until achievement of target blood pressure was 28.0 (1.0-365.0) days. Conclusion: Pediatric HT is an often overlooked growing medical issue. Secondary HT was found more in children compare to primary HT. Secondary etiology was suspected if HT was found in children with kidney disease. The first-line antihypertensive drug used was ACEI, as single or combination therapy. The therapeutic effect of antihypertensive drugs was expected within 28 days of treatment.

🔖

Bu Makaleye Atıf Yap

PUSPİTASARİ, H. A., INDRİASTİ, N., HİDAYATİ, E. L. (2021). Antihypertensive Management in Children: A Two-years Experience of Indonesia’s National Referral Hospital. The anatolian journal of family medicine (Online), Cilt: 4 - Sayı: 1, 7–12. https://ajindex.com/articles/365000

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Gupta-Malhotra M, Banker A, Shete S, Hashmi SS, Tyson JE, Barratt MS, et al. Essential hypertension vs. secondary hyper- tension among children. Am J Hypertens 2015;28(1):73–80
  2. National Institute of Health. The fourth report on diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, 1996. Available at: https://www.nhlbi.nih. gov/files/docs/resources/heart/hbp_ped.pdf. Accessed Dec 21, 2020
  3. Flynn JT, Falkner BE. Obesity hypertension in adolescents: epi- demiology, evaluation, and management. J Clin Hypertens (Greenwich) 2011;13(5):323–31
  4. Edvardsson VO, Steinthorsdottir SD, Eliasdottir SB, Indridason OS, Palsson R. Birth weight and childhood blood pressure. Curr Hypertens Rep 2012;14(6):596–602
  5. Mhanna MJ, Iqbal AM, Kaelber DC. Weight gain and hyper- tension at three years of age and older in extremely low birth weight infants. J Neonatal Perinatal Med 2015;8(4):363–9
  6. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The rela- tion of overweight to cardiovascular risk factors among chil- dren and adolescents: the Bogalusa heart study. Pediatrics 1999;103(6 Pt 1):1175–82
  7. Maldonado J, Pereira T, Fernandes R, Carvalho M. Blood pres- sure distribution of a sample of healthy Portuguese children and adolescents: the AVELEIRA registry. Rev Port Cardiol 2009;28(11):1233–44
  8. Salvadori M, Sontrop JM, Garg AX, Truong J, Suri RS, Mahmud FH, et al. Elevated blood pressure in relation to overweight and obesity among children in a rural Canadian community. Pediatrics 2008;122(4):e821–7
  9. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Over- weight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004;113(3 Pt 1):475–82
  10. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hy- pertension 2008;52(4):631–7
  11. Samuels J, Ng D, Flynn JT, Mitsnefes M, Poffenbarger T, Warady BA, et al. Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension 2012;60(1):43–50
  12. Shatat IF, Flynn JT. Hypertension in children with chronic kid- ney disease. Adv Chronic Kidney Dis 2005;12(4):378–84
  13. Chavers BM, Solid CA, Daniels FX, Chen SC, Collins AJ, Fran- kenfield DL, et al. Hypertension in pediatric long-term hemo- dialysis patients in the United States. Clin J Am Soc Nephrol 2009;4(8):1363–9
  14. Kramer AM, van Strale